Prothena Historical Cash Flow
| PRTA Stock | USD 15.14 0.60 3.81% |
Analysis of Prothena Plc cash flow over time is an excellent tool to project Prothena plc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Financing Activities of 42.8 M or End Period Cash Flow of 440.1 M as it is a great indicator of Prothena Plc ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Prothena plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Prothena plc is a good buy for the upcoming year.
Prothena |
About Prothena Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Prothena balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Prothena's non-liquid assets can be easily converted into cash.
Prothena Plc Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Capital Expenditures
Capital Expenditures are funds used by Prothena plc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Prothena Plc operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Prothena Plc's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Prothena plc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.At present, Prothena Plc's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Financing Activities is expected to grow to about 34 M, whereas Free Cash Flow is projected to grow to (129.9 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 575K | 464K | 2.8M | 1.9M | Depreciation | 6.8M | 744K | 928K | 881.6K |
Prothena Plc cash flow statement Correlations
Click cells to compare fundamentals
Prothena Plc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Prothena Plc cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Stock Based Compensation | 23.6M | 22.0M | 24.7M | 31.3M | 40.9M | 43.0M | |
| Free Cash Flow | (53.5M) | (80.6M) | 92.0M | (109.3M) | (136.7M) | (129.9M) | |
| Change In Working Capital | (4.4M) | 3.5M | (10.4M) | (18.8M) | (20.5M) | (19.5M) | |
| Other Cashflows From Financing Activities | 228K | 215K | 15.5M | 17.8M | 21.5M | 34.0M | |
| Depreciation | 6.8M | 7.0M | 6.8M | 744K | 928K | 881.6K | |
| Capital Expenditures | 555K | 196K | 575K | 464K | 2.8M | 1.9M | |
| Total Cash From Operating Activities | (53.0M) | (80.4M) | 92.6M | (108.8M) | (133.9M) | (127.2M) | |
| Net Income | (77.7M) | (111.1M) | 67.0M | (116.9M) | (147.0M) | (139.7M) | |
| Total Cash From Financing Activities | 228K | 215K | 190.3M | 241.5M | 45.1M | 42.8M | |
| Change To Inventory | (396.2M) | 9.6M | (10.3M) | (8.9M) | (10.2M) | (10.7M) | |
| Change In Cash | (53.3M) | (80.3M) | 282.4M | 132.2M | (91.6M) | (87.0M) | |
| End Period Cash Flow | 378.4M | 298.1M | 580.4M | 712.6M | 621.0M | 440.1M | |
| Sale Purchase Of Stock | 44.4M | 228K | 215K | 93.6M | 84.2M | 69.8M | |
| Change Receivables | (62K) | 238K | 53K | 15K | 17.3K | 16.4K | |
| Begin Period Cash Flow | 431.7M | 378.4M | 298.1M | 580.4M | 712.6M | 418.0M | |
| Total Cashflows From Investing Activities | (547K) | (196K) | (575K) | (464K) | (533.6K) | (560.3K) | |
| Other Non Cash Items | 37.3M | 28.2M | 38.7M | 6.0M | 7.5M | 12.0M | |
| Cash And Cash Equivalents Changes | 10.0M | (53.3M) | (80.3M) | 282.4M | 324.7M | 341.0M | |
| Cash Flows Other Operating | 39.8M | 24.9M | 23.2M | 20.1M | 23.1M | 12.8M | |
| Change To Operating Activities | (4.4M) | (4.3M) | (10.3M) | (16.8M) | (15.1M) | (14.4M) | |
| Other Cashflows From Investing Activities | 105K | 39K | 8K | 37K | 42.6K | 33.7K | |
| Change To Netincome | (1.2M) | (1.7M) | 4.6M | 20.2M | 23.2M | 24.4M | |
| Change To Liabilities | (539K) | 7.7M | (144K) | (2.0M) | (1.8M) | (1.7M) | |
| Investments | (547K) | (196K) | (575K) | (464K) | (1.4M) | (1.5M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Revenue Per Share 2.482 | Quarterly Revenue Growth (0.99) | Return On Assets (0.16) | Return On Equity (0.23) |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.